Literature DB >> 21478267

FOXD3 regulates migration properties and Rnd3 expression in melanoma cells.

Pragati Katiyar1, Andrew E Aplin.   

Abstract

Forkhead transcription factor, Foxd3, plays a critical role during development by controlling the lineage specification of neural crest cells. Notably, Foxd3 is highly expressed during the wave of neural crest cell migration that forms peripheral neurons and glial cells but is downregulated prior to migration of cells that give rise to the melanocytic lineage. Melanoma is the deadliest form of skin cancer and is derived from melanocytes. Recently, we showed that FOXD3 expression is elevated following the targeted inhibition of the B-RAF-MEK (MAP/ERK kinase)-ERK (extracellular signal-regulated kinase)1/2 pathway in mutant B-RAF melanoma cells. Because melanoma cells are highly migratory and invasive in a B-RAF-dependent manner, we explored the role of FOXD3 in these processes. In this study, we show that ectopic FOXD3 expression inhibits the migration, invasion, and spheroid outgrowth of mutant B-RAF melanoma cells. Upregulation of FOXD3 expression following inhibition of B-RAF and MEK correlates with the downregulation of Rnd3, a Rho GTPase and inhibitor of RhoA-ROCK signaling. Indeed, expression of FOXD3 alone was sufficient to downregulate Rnd3 expression at the mRNA and protein levels. Mechanistically, FOXD3 was found to be recruited to the Rnd3 promoter. Inhibition of ROCK partially restored migration in FOXD3-expressing cells. These data show that FOXD3 expression downregulates migration and invasion in melanoma cells and Rnd3, a target known to be involved in these properties.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21478267      PMCID: PMC3096755          DOI: 10.1158/1541-7786.MCR-10-0454

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  40 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo.

Authors:  Lynn A Hanna; Ruth K Foreman; Illya A Tarasenko; Daniel S Kessler; Patricia A Labosky
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

3.  RhoE binds to ROCK I and inhibits downstream signaling.

Authors:  Kirsi Riento; Rosa M Guasch; Ritu Garg; Boquan Jin; Anne J Ridley
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

4.  The fork head domain: a novel DNA binding motif of eukaryotic transcription factors?

Authors:  D Weigel; H Jäckle
Journal:  Cell       Date:  1990-11-02       Impact factor: 41.582

5.  Rnd proteins function as RhoA antagonists by activating p190 RhoGAP.

Authors:  Krister Wennerberg; Marie-Annick Forget; Shawn M Ellerbroek; William T Arthur; Keith Burridge; Jeffrey Settleman; Channing J Der; Steen H Hansen
Journal:  Curr Biol       Date:  2003-07-01       Impact factor: 10.834

6.  Suppression of BRAF(V599E) in human melanoma abrogates transformation.

Authors:  Sunil R Hingorani; Michael A Jacobetz; Gavin P Robertson; Meenhard Herlyn; David A Tuveson
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

7.  Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference.

Authors:  Hidetoshi Sumimoto; Makoto Miyagishi; Hiroyuki Miyoshi; Shizuko Yamagata; Ayako Shimizu; Kazunari Taira; Yutaka Kawakami
Journal:  Oncogene       Date:  2004-08-12       Impact factor: 9.867

8.  ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility.

Authors:  Emmanuel Vial; Erik Sahai; Christopher J Marshall
Journal:  Cancer Cell       Date:  2003-07       Impact factor: 31.743

9.  Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling.

Authors:  Jonathan T Huntington; Janiel M Shields; Channing J Der; Colby A Wyatt; Ulrike Benbow; Craig L Slingluff; Constance E Brinckerhoff
Journal:  J Biol Chem       Date:  2004-06-07       Impact factor: 5.157

10.  Adhesion-dependent activation of the ERK1/2 cascade is by-passed in melanoma cells.

Authors:  Sean R Conner; Glynis Scott; Andrew E Aplin
Journal:  J Biol Chem       Date:  2003-06-23       Impact factor: 5.157

View more
  20 in total

Review 1.  Pathophysiological Functions of Rnd3/RhoE.

Authors:  Wei Jie; Kelsey C Andrade; Xi Lin; Xiangsheng Yang; Xiaojing Yue; Jiang Chang
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

2.  FOXD3 modulates migration through direct transcriptional repression of TWIST1 in melanoma.

Authors:  Michele B Weiss; Ethan V Abel; Neda Dadpey; Andrew E Aplin
Journal:  Mol Cancer Res       Date:  2014-07-24       Impact factor: 5.852

3.  Screening of FOXD3 targets in lung cancer via bioinformatics analysis.

Authors:  Wenhua Jiang; Pengfei Liu; Xiaodong Li
Journal:  Oncol Lett       Date:  2017-12-21       Impact factor: 2.967

4.  PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma.

Authors:  Jennifer D Kubic; Jason W Lui; Elizabeth C Little; Anton E Ludvik; Sasank Konda; Ravi Salgia; Andrew E Aplin; Deborah Lang
Journal:  J Biol Chem       Date:  2015-07-23       Impact factor: 5.157

5.  FoxD3 regulates cranial neural crest EMT via downregulation of tetraspanin18 independent of its functions during neural crest formation.

Authors:  Corinne L Fairchild; Joseph P Conway; Andrew T Schiffmacher; Lisa A Taneyhill; Laura S Gammill
Journal:  Mech Dev       Date:  2014-02-28       Impact factor: 1.882

6.  Downregulation of the transcription factor, FoxD3, is associated with lymph node metastases in invasive ductal carcinomas of the breast.

Authors:  Hua Zhao; Daozhen Chen; Jiayuan Wang; Yongxiang Yin; Qiong Gao; Ye Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

7.  RhoJ modulates melanoma invasion by altering actin cytoskeletal dynamics.

Authors:  Hsiang Ho; Amelia Soto Hopkin; Rubina Kapadia; Priya Vasudeva; Jonathan Schilling; Anand K Ganesan
Journal:  Pigment Cell Melanoma Res       Date:  2013-01-07       Impact factor: 4.693

8.  FOXD3 Promotes PAX3 Expression in Melanoma Cells.

Authors:  Jennifer D Kubic; Elizabeth C Little; Rebecca S Kaiser; Kacey P Young; Deborah Lang
Journal:  J Cell Biochem       Date:  2015-09-01       Impact factor: 4.429

9.  Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011".

Authors:  Paolo A Ascierto; Antonio M Grimaldi; Brendan Curti; Mark B Faries; Soldano Ferrone; Keith Flaherty; Bernard A Fox; Thomas F Gajewski; Jeffrey E Gershenwald; Helen Gogas; Kenneth Grossmann; Axel Hauschild; F Stephen Hodi; Richard Kefford; John M Kirkwood; Sancy Leachmann; Michele Maio; Richard Marais; Giuseppe Palmieri; Donald L Morton; Antoni Ribas; David F Stroncek; Rodney Stewart; Ena Wang; Nicola Mozzillo; Franco M Marincola
Journal:  J Transl Med       Date:  2012-07-04       Impact factor: 5.531

Review 10.  Function and regulation of Rnd proteins in cortical projection neuron migration.

Authors:  Roberta Azzarelli; François Guillemot; Emilie Pacary
Journal:  Front Neurosci       Date:  2015-02-06       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.